As of 2025-09-18, the Relative Valuation of Amneal Pharmaceuticals Inc (AMRX) is 0.38 USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.61 USD, the upside of Amneal Pharmaceuticals Inc based on Relative Valuation is -96.1%.
The range of the Relative Valuation is 0.30 - 0.46 USD.
| Range | Selected | |
| Trailing P/E multiples | 31.0x - 43.0x | 35.2x |
| Forward P/E multiples | 27.9x - 42.0x | 34.8x |
| Fair Price | 0.30 - 0.46 | 0.38 |
| Upside | -96.9% - -95.2% | -96.1% |
| Date | P/E |
| 2025-09-11 | 938.98 |
| 2025-09-10 | 913.86 |
| 2025-09-09 | 920.37 |
| 2025-09-08 | 905.48 |
| 2025-09-05 | 895.24 |
| 2025-09-04 | 888.73 |
| 2025-09-03 | 887.80 |
| 2025-09-02 | 891.52 |
| 2025-08-29 | 889.66 |
| 2025-08-28 | 888.73 |
| 2025-08-27 | 871.05 |
| 2025-08-26 | 872.91 |
| 2025-08-25 | 863.60 |
| 2025-08-22 | 892.45 |
| 2025-08-21 | 886.87 |
| 2025-08-20 | 875.70 |
| 2025-08-19 | 868.26 |
| 2025-08-18 | 861.74 |
| 2025-08-15 | 879.42 |
| 2025-08-14 | 873.84 |
| 2025-08-13 | 874.77 |
| 2025-08-12 | 839.41 |
| 2025-08-11 | 822.66 |
| 2025-08-08 | 794.74 |
| 2025-08-07 | 764.03 |
| 2025-08-06 | 749.14 |
| 2025-08-05 | 756.58 |
| 2025-08-04 | 740.76 |
| 2025-08-01 | 728.67 |
| 2025-07-31 | 727.73 |
| 2025-07-30 | 751.00 |
| 2025-07-29 | 752.86 |
| 2025-07-28 | 760.31 |
| 2025-07-25 | 750.07 |
| 2025-07-24 | 744.49 |
| 2025-07-23 | 751.00 |
| 2025-07-22 | 740.76 |
| 2025-07-21 | 736.11 |
| 2025-07-18 | 741.69 |
| 2025-07-17 | 766.82 |
| 2025-07-16 | 768.68 |
| 2025-07-15 | 769.61 |
| 2025-07-14 | 783.57 |
| 2025-07-11 | 775.20 |
| 2025-07-10 | 780.78 |
| 2025-07-09 | 775.20 |
| 2025-07-08 | 767.75 |
| 2025-07-07 | 782.64 |
| 2025-07-03 | 783.57 |
| 2025-07-02 | 778.92 |